4-Oxalocrotonate tautomera
se (4-OT), a homohexameric enzyme, convert
s the unconjugatedenone, 2-oxo-4-hexenedioate (
1), to the conjugated enone, 2-oxo-3-hexenedioate (
3), via a dienolicintermediate, 2-hydroxymuconate (
2). Pro-1
serve
s a
s the general ba
se,
and both Arg-11
and Arg-39function in
sub
strate binding
and cataly
si
s in an otherwi
se hydrophobic active
site. Although 4-OT exhibit
shyperbolic kinetic
s and no
structural a
symmetry either by X-ray or by NMR, inactivation by two affinitylabel
s showed half-
site
stoichiometry [Stiver
s, J. T., et al. (1996)
Biochemistry 35, 803-813; John
son,W. H., Jr., et al. (1997)
Biochemistry 36, 15724-15732],
and titration of the R39Q mutant with
cis,
cis-muconate
showed negative cooperativity [Harri
s, T. K., et al. (1999)
Biochemistry 38, 12343-12357].To te
st for anticooperativity during cataly
si
s, 4-OT wa
s titrated with equilibrium mixture
s (
![](/image<font color=)
s/entitie
s/ge.gif">81% product)of the reactive dicarboxylate or monocarboxylate intermediate
s,
2 or 2-hydroxy-2,4-pentadienoate (
4),re
spectively, in three type
s of NMR experiment
s: two-dimen
sional
1H-
15N HSQC titration
s of backboneNH
and of Arg N
![](/image<font color=)
s/gifchar
s/ep
silon.gif" BORDER=0 >H re
sonance
s and one-dimen
sional
15N NMR titration
s of Arg N
![](/image<font color=)
s/gifchar
s/ep
silon.gif" BORDER=0 > re
sonance
s. Alltitration
s showed
sub
stoichiometric binding of the equilibrium mixture
s to 3 ± 1
site
s per hexamer withapparent di
ssociation con
stant
s comparable to the
Km value
s of the intermediate
s. Compound
4 al
so bound1 order of magnitude le
ss tightly at another
site,
sugge
sting negative cooperativity. Con
si
stent with negativecooperativity, a
symmetry of the re
sulting complexe
s at
saturating level
s of
2 and 4 i
s indicated by
splittingof the backbone NH re
sonance
s of 11 re
sidue
s and 10 re
sidue
s of 4-OT, re
spectively. The dicarboxylatecompetitive inhibitor, (2
E)-fluoromuconate (
5), with a
KI of 45 ± 7
![](/image<font color=)
s/entitie
s/mgr.gif">M, al
so exhibited
sub
stoichiometricbinding to 3 ± 1
site
s per hexamer, with a
KD of 25 ± 18
![](/image<font color=)
s/entitie
s/mgr.gif">M,
and splitting of the backbone NH re
sonanceof L8. The monocarboxylate inhibitor
s (2
E)- (
6)
and (2
Z)-2-fluoro-2,4-pentadienoate (
7)
showed muchweaker binding (
KD = 3.1 ± 1.3 mM), a
s well a
s splitting of two
and five backbone NH re
sonance
s,re
spectively, indicating a
symmetry of the complexe
s. The N
![](/image<font color=)
s/gifchar
s/ep
silon.gif" BORDER=0 > re
sonance
s of both Arg-11
and Arg-39were
shifted downfield,
and that of Pro-1N wa
s broadened by all lig
ands, con
si
stent with the major catalyticrole
s of the
se re
sidue
s. Structural pathway
s for the
site-
site interaction
s which re
sult in negativecooperativity are propo
sed on the ba
si
s of the X-ray
structure
s of free
and affinity-labeled 4-OT. Selectivere
sonance broadening
s induced by the binding of inactive analogue
s and active intermediate
s indicatere
sidue
s which may be mobilized during rever
sible lig
and binding
and during cataly
si
s, re
spectively.